ALPINE GROUP PARTNERS, LLC. lobbying for ULTRAGENYX PHARMACEUTICAL INC.

Filing Registration

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Jul 13, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

California

Official filing document

Lobbyists on this filing 3

KEENAN AUSTIN REED New on this filing

Previously held: Chief of Staff, Rep. Donald McEachin; Deputy Chief of Staff, Rep. Frederica S. Wilson
ERIN MENDELSOHN New on this filing

Previously held: LD, Rep. Anna Eshoo; Congressional Liaison - FDA
SHAYNE WOODS New on this filing

Previously held: Senior Legislative Assistant, Sen. Tim Scott; Senior Policy Advisor, Rep. Gus Bilirakis

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 3

Health Issues

Monitoring FDA user fee regulation, including priority review voucher reauthorization; legislation around screening efforts for newborns and ultra-rare diseases like Duchenne Muscular Dystrophy (DMD) and Metachromatic Leukodystrophy (MLD)

Government Issues

Monitoring FDA user fee regulation, including priority review voucher reauthorization; legislation around screening efforts for newborns and ultra-rare diseases like Duchenne Muscular Dystrophy (DMD) and Metachromatic Leukodystrophy (MLD)

Medical/Disease Research/Clinical Labs

Monitoring FDA user fee regulation, including priority review voucher reauthorization; legislation around screening efforts for newborns and ultra-rare diseases like Duchenne Muscular Dystrophy (DMD) and Metachromatic Leukodystrophy (MLD)